Introduction
RIFAXIKEM 550 is formulated as an oral tablet containing Rifaximin 550 mg, a semisynthetic, rifamycin-based antibiotic specifically designed to act locally in the gastrointestinal tract with minimal systemic absorption. Each rifaximin 550 mg tablet is film-coated and composed of rifaximin as the active ingredient along with excipients such as microcrystalline cellulose, colloidal silicon dioxide, glycerol palmitostearate, polyethylene glycol, red iron oxide, sodium starch glycolate, talc, and titanium dioxide to ensure consistent effectiveness and stability.
Mechanism of Action
The mechanism of action of rifaximin involves inhibition of bacterial RNA synthesis by binding to the beta-subunit of bacterial DNA-dependent RNA polymerase. This effect halts bacterial protein synthesis, resulting in bactericidal activity against Gram-positive and Gram-negative enteric pathogens. Due to its poor systemic absorption, rifaximin 550 mg acts locally within the gut, making it effective for intestinal infections with a reduced risk of systemic side effects.
Uses and Indications
The primary rifaximin 550 mg uses include:
Treatment and prevention of traveler’s diarrhea caused by noninvasive strains of Escherichia coli
Management of irritable bowel syndrome with diarrhea (IBS-D) to reduce symptoms and improve quality of life
Prevention of hepatic encephalopathy recurrence by reducing ammonia-producing gut bacteria
Treatment of small intestinal bacterial overgrowth (SIBO) and other gastrointestinal infections as clinically indicated
Dosage and Administration
For hepatic encephalopathy prevention: 550 mg (one rifaximin 550 mg tablet) twice daily
For IBS-D: 550 mg three times daily for 14 days
For traveler’s diarrhea, usually the 200 mg formulation is used, but rifaximin tablets 550 mg are preferred for the above chronic indications
Tablets should be swallowed whole, with or without food, as prescribed by the healthcare provider
Efficacy and Clinical Evidence
Clinical trials have demonstrated the efficacy of rifaximin 550 mg in reducing symptoms and recurrence of hepatic encephalopathy, improving bowel symptoms in IBS-D patients, and effectively treating traveler's diarrhea. Its local gut action and excellent safety profile make it a valuable antibiotic choice for intestinal infections and related conditions.
Side Effects and Safety Profile
Rifaximin 550 mg is generally well tolerated. Common side effects include nausea, headache, dizziness, and mild gastrointestinal discomfort. Serious adverse events are rare but may include allergic reactions or liver function abnormalities. Due to minimal systemic absorption, the safety profile of rifaximin tablet is superior to many systemic antibiotics.
Contraindications and Precautions
Known hypersensitivity to rifaximin or rifamycin antibiotics
Use with caution in severe liver impairment
Not recommended for diarrhea associated with fever or blood in stools, as these may indicate non-bacterial causes or invasive infections
Drug Interactions
Rifaximin 550 mg has minimal drug interaction potential due to poor systemic absorption but caution is advised with agents affecting liver enzymes or gut flora balance.
Warnings and Regulatory Status
Rifaximin tablets 550 mg are approved by regulatory authorities such as the FDA for indicated uses and must be used under medical supervision. The drug should not be used indiscriminately to avoid antibiotic resistance.
Patient Advice and Tips
Adhere strictly to prescribed dosing and duration
Inform healthcare providers about all medications and health conditions
Avoid alcohol during therapy to reduce liver burden
Report any unusual side effects or worsening symptoms promptly
Availability
RIFAXIKEM 550 is widely available as oral tablets containing rifaximin 550 mg, marketed globally in various formulations under different brand names.
Frequently Asked Questions :
Q1. What is Rifaximin 550 mg used for?
IBS-D, hepatic encephalopathy & traveler's diarrhea.
Q2. Is Rifaximin 550 mg an antibiotic?
Yes, it's a gut-specific antibiotic.
Q3. How to take Rifaximin tablets 550 mg?
As prescribed, usually once or twice daily.
Q4. Common side effects of Rifaximin 550?
Nausea, bloating, headache, stomach pain.
Q5. Is Rifaximin 550 mg safe long-term?
Only under doctor’s supervision.
Q6. Can I take cap Rifaximin 550 in pregnancy?
Not recommended without doctor’s advice.
Q7. Any drug interactions?
Yes, consult your doctor before combining.
Q8. Where to buy Rifaximin tablet?
Available via Steris Healthcare Pvt. Ltd
Why Choose Steris Healthcare Pvt Ltd?
Commitment to high-quality formulation meeting stringent WHO, GMP, and ISO standards
Reliable manufacturing and supply ensuring consistent availability of rifaximin tablets 550 mg
Affordability combined with clinical-grade efficacy
Dedicated customer support and healthcare partnerships for patient education and assistance
Conclusion
RIFAXIKEM 550, containing rifaximin 550 mg, is a powerful and targeted treatment option for conditions such as hepatic encephalopathy, IBS-D, and traveler’s diarrhea. With a well-established safety profile and minimal systemic absorption, this rifaximin tablet offers effective relief with fewer systemic side effects. Clinical evidence supports its long-term use under medical supervision, making rifaximin tablets 550 mg a preferred choice in both acute and chronic gastrointestinal conditions. For those seeking quality and trust, Steris Healthcare Pvt. Ltd. delivers rifaximin 550 with high manufacturing standards and reliable therapeutic outcomes. Always consult your healthcare provider before starting any new medication.
